SCHEMBL1742347

SCHEMBL1742347

NC(=[Se])C1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1741972 0.83
SCHEMBL388062 0.78
SCHEMBL3694046 0.78
SCHEMBL12696676 0.78
Hydrochloric Acid SCHEMBL7488148 0.77 NOS2 (0.47)
Hydrochloric Acid SCHEMBL4715841 0.77 SLC6A2 (0.46)
Hydrochloric Acid SCHEMBL7845217 0.77 SLC6A2 (0.46)
Bromide SCHEMBL27569518 0.77 NOS2 (0.47)
SCHEMBL5461286 0.77 SSTR4 (0.41)
SCHEMBL7320391 0.74 SSTR4 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2389371-A2 BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2011-11-30 EP disclosed
WO-2010085352-A2 BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2010-07-29 WO disclosed